Gentofte Hospital is located in Gentofte within Copenhagen in Denmark. Administratively, it is part of the hospital service of Region Hovedstaden. The hospital primarily serves the municipalities of Gentofte, Lyngby-Taarbæk, and Rudersdal, with a population of about 175,000.

During the past decade, Gentofte Hospital conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 23 clinical trials were completed, i.e. on average, 24% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 15 clinical trials were completed. i.e. 39.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gentofte Hospital" #1 sponsor was "University Hospital, Gentofte, Copenhagen" with 27 trials, followed by "Rigshospitalet, Denmark" with 19 trials sponsored, "Herlev and Gentofte Hospital" with 10 trials sponsored, "Boehringer Ingelheim" with 5 trials sponsored and "Chronic Obstructive Pulmonary Disease Trial Network, Denmark" with 5 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gentofte Hospital" #1 collaborator was "University of Copenhagen" with 9 trials as a collaborator, "Aarhus University Hospital" with 8 trials as a collaborator, "Odense University Hospital" with 7 trials as a collaborator, "University Hospital, Gentofte, Copenhagen" with 6 trials as a collaborator and "Aalborg University Hospital" with 4 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "Gentofte Hospital" are "Heart Failure" (10 trials), "Psoriasis" (10 trials), "Atrial Fibrillation" (9 trials), "Idiopathic Pulmonary Fibrosis" (6 trials) and "COPD" (5 trials). Many other conditions were trialed in "Gentofte Hospital" in a lesser frequency.

Most popular intervention types in "Gentofte Hospital" are "Drug" (76 trials), "Device" (32 trials), "Other" (28 trials), "Procedure" (15 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "O2matic" (4 trials), "Saline" (4 trials), "Alpha-1 MP" (2 trials) and "Apixaban Oral Tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gentofte Hospital" are 156 trials for "All" genders, 9 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 44 active trials in "Gentofte Hospital". 3 are not yet recruiting, 27 are recruiting, 12 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 103 completed trials in Gentofte Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Gentofte Hospital, 7 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 35 trials, and there were also 56 trials that are defined as “Not Applicable".

Gentofte Hospital has several departments that took part in Clinical trials: "Center for Diabetes Research, Gentofte Hospital" - 13 trials, "Department of Anaesthesia-Surgery-Intensive Care, Gentofte Hospital" - 3 trials, "Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte" - 2 trials